TRDA vs ZION · P/E 12, rev $1.8M vs P/E 11, rev $354.0M
Entrada Therapeutics Inc (TRDA) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported TRDA revenue for 2026-06-30 was $1.8M. Net income was -$82.5M. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
TRDA currently screens at market cap $274.4M and trailing P/E 12.5. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the TRDA and ZION stock pages for the full models.
Not investment advice.